The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.
ZyCoV-D is a three-dose vaccine administered intradermally.
Some of these items of consumption include ultraviolet disinfectants and sanitising boxes, free-finger touch devices, do-it-yourself grooming kits, self-cleaning water bottles, smart tiffin boxes, hand-sanitizer wearables, antiviral fabrics, tiles, flooring and mattresses, and anti-fogging glasses.
A back of the envelope calculation shows that India has roughly over 680 million doses of Covid-19 vaccines consisting primarily of Covishield doses.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
'Is it advisable to have more number of scrips in small quantities or a few scrips in big quantities?'
Investors indulged in buying beaten down blue chips at lower and attractive levels.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances